OliX Pharmaceuticals,Inc (226950.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−42.4x

Market Cap

KRW 1.85T

MomentumView details →

1D Return

−8.38%

YTD Return

−31.70%

RSI (14)

41.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−42.4x

Market Cap

KRW 1.85T

RSI (14)

41.4

MomentumView details →

1D Return

−8.38%

YTD Return

−31.70%

ProfitabilityView details →

Gross Margin

87.24%

Net Margin

−102.89%

EBITDA Margin

−287.66%

ROE (TTM)

−5.93%

ROA (TTM)

−5.12%

Asset Turnover

0.06x

GrowthView details →

Revenue YoY

+80.93%

EPS YoY

+76.10%

FCF YoY

+0.31%

Revenue CAGR 3Y

+16.31%

EPS CAGR 3Y

+66.54%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−KRW 439.87

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

11.74x

Quick Ratio

11.71x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

13.64B

Net Income (TTM)

−14.03B

Op. CF (TTM)

−30.08B

Latest newsMore news →

No recent news for 226950.KQ.

Similar companies

Kolon TissueGene, Inc.950160.KQ Voronoi, Inc.310210.KQ D&D Pharmatech347850.KQ SK bioscience Co.,Ltd.302440.KS Orum Therapeutics, Inc.475830.KQ Hugel, Inc.145020.KQ Find similar companies →

Latest newsMore news →

No recent news for 226950.KQ.